Cargando…
Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease
Insulin resistance (IR) is defined as a lower-than-expected response to insulin action from target tissues, leading to the development of type 2 diabetes through the impairment of both glucose and lipid metabolism. IR is a common condition in subjects with nonalcoholic fatty liver disease (NAFLD) an...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000048/ https://www.ncbi.nlm.nih.gov/pubmed/33800465 http://dx.doi.org/10.3390/metabo11030155 |
_version_ | 1783670917655691264 |
---|---|
author | Armandi, Angelo Rosso, Chiara Caviglia, Gian Paolo Bugianesi, Elisabetta |
author_facet | Armandi, Angelo Rosso, Chiara Caviglia, Gian Paolo Bugianesi, Elisabetta |
author_sort | Armandi, Angelo |
collection | PubMed |
description | Insulin resistance (IR) is defined as a lower-than-expected response to insulin action from target tissues, leading to the development of type 2 diabetes through the impairment of both glucose and lipid metabolism. IR is a common condition in subjects with nonalcoholic fatty liver disease (NAFLD) and is considered one of the main factors involved in the pathogenesis of nonalcoholic steatohepatitis (NASH) and in the progression of liver disease. The liver, the adipose tissue and the skeletal muscle are major contributors for the development and worsening of IR. In this review, we discuss the sites and mechanisms of insulin action and the IR-related impairment along the spectrum of NAFLD, from simple steatosis to progressive NASH and cirrhosis. |
format | Online Article Text |
id | pubmed-8000048 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80000482021-03-28 Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease Armandi, Angelo Rosso, Chiara Caviglia, Gian Paolo Bugianesi, Elisabetta Metabolites Review Insulin resistance (IR) is defined as a lower-than-expected response to insulin action from target tissues, leading to the development of type 2 diabetes through the impairment of both glucose and lipid metabolism. IR is a common condition in subjects with nonalcoholic fatty liver disease (NAFLD) and is considered one of the main factors involved in the pathogenesis of nonalcoholic steatohepatitis (NASH) and in the progression of liver disease. The liver, the adipose tissue and the skeletal muscle are major contributors for the development and worsening of IR. In this review, we discuss the sites and mechanisms of insulin action and the IR-related impairment along the spectrum of NAFLD, from simple steatosis to progressive NASH and cirrhosis. MDPI 2021-03-08 /pmc/articles/PMC8000048/ /pubmed/33800465 http://dx.doi.org/10.3390/metabo11030155 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Review Armandi, Angelo Rosso, Chiara Caviglia, Gian Paolo Bugianesi, Elisabetta Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease |
title | Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease |
title_full | Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease |
title_fullStr | Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease |
title_full_unstemmed | Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease |
title_short | Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease |
title_sort | insulin resistance across the spectrum of nonalcoholic fatty liver disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000048/ https://www.ncbi.nlm.nih.gov/pubmed/33800465 http://dx.doi.org/10.3390/metabo11030155 |
work_keys_str_mv | AT armandiangelo insulinresistanceacrossthespectrumofnonalcoholicfattyliverdisease AT rossochiara insulinresistanceacrossthespectrumofnonalcoholicfattyliverdisease AT cavigliagianpaolo insulinresistanceacrossthespectrumofnonalcoholicfattyliverdisease AT bugianesielisabetta insulinresistanceacrossthespectrumofnonalcoholicfattyliverdisease |